Therapie des fortgeschrittenen Basalzellkarzinoms mittels Hedgehog-Inhibition

• Literatur

• 1 Rubin AI, Chen EH, Ratner D. Basal-cell carcinoma. N Engl J Med 2005; 353: 2262-2269
• 2 Bale AE, Yu KP. The hedgehog pathway and basal cell carcinomas. Hum Mol Genet 2001; 10: 757-762
• 3 Hutchin ME, Kariapper MS, Grachtchouk M. et al. Sustained hedgehog signaling is required for basal cell carcinoma proliferation and survival: conditional skin tumorigenesis recapitulates the hair growth cycle. Genes Dev 2005; 19: 214-223
• 4 Teh MT, Blaydon D, Chaplin T. et al. Genomewide single nucleotide polymorphism microarray mapping in basal cell carcinomas unveils uniparental disomy as a key somatic event. Cancer Res 2005; 65: 8597-8603
• 5 Scales SJ, de Sauvage FJ. Mechanisms of Hedgehog pathway activation in cancer and implications for therapy. Trends Pharmacol Sci 2009; 30: 303-312
• 6 Kakkassery V, Loeffler KU, Sand M. et al. Current diagnostics and therapy recommendations for ocular basal cell carcinoma. Ophthalmologe 2017; 114: 224-236
• 7 Sekulic A, Mangold AR, Northfelt DW. et al. Advanced basal cell carcinoma of the skin: targeting the hedgehog pathway. Curr Opin Oncol 2013; 25: 218-223
• 8 Papastefanou VP, René C. Secondary resistance to vismodegib after initial successful treatment of extensive recurrent periocular basal cell carcinoma with orbital invasion. Ophthal Plast Reconstr Surg 2017; 33 (3S Suppl 1): S68-S70